Table 3. Survival Model Results for the Relation Between Benign Gynecologic Surgery Status and Cancer Mortality, According to the Age by Which Surgeries Were Performed: US BCDDP Follow-up Study With Follow-up From 1979-1986 to 2005 (n=52,846).
Benign gynecological surgery status | All cancers (No. deaths=4,326) | Lung (No. deaths=914) | Breast (No. deaths=734) | CRC (No. deaths=384) | Pancreas (No. deaths=322) | NHL (No. deaths=236) |
---|---|---|---|---|---|---|
Age at surgery | ||||||
≤35 years | ||||||
None | ||||||
No. of deaths | 4,076 | 859 | 697 | 362 | 299 | 222 |
HRa | ref | ref | ref | ref | ref | ref |
TAH | ||||||
No. of deaths | 153 | 33 | 25 | 7 | 9 | 10 |
HRa | 1.00 | 1.00 | 0.93 | 0.51 | 0.76 | 1.20 |
95% CI | 0.85, 1.18 | 0.70, 1.42 | 0.62, 1.38 | 0.24, 1.08 | 0.39, 1.49 | 0.63, 2.28 |
BSO | ||||||
No. of deaths | 97 | 22 | 12 | 15 | 14 | 4 |
HRa | 1.14 | 1.17 | 0.88 | 1.92 | 2.09 | 0.84 |
95% CI | 0.93, 1.39 | 0.77, 1.80 | 0.49, 1.56 | 1.13, 3.23 | 1.21, 3.60 | 0.31, 2.28 |
≤40 years | ||||||
None | ||||||
No. of deaths | 3,779 | 784 | 646 | 338 | 283 | 200 |
HRa | ref | ref | ref | ref | ref | ref |
TAH | ||||||
No. of deaths | 374 | 85 | 66 | 27 | 22 | 28 |
HRa | 1.04 | 1.12 | 1.04 | 0.83 | 0.76 | 1.50 |
95% CI | 0.94, 1.17 | 0.89, 1.41 | 0.80, 1.35 | 0.55, 1.23 | 0.49, 1.19 | 1.00, 2.25 |
BSO | ||||||
No. of deaths | 173 | 45 | 22 | 19 | 17 | 8 |
HRa | 0.92 | 1.14 | 0.73 | 1.09 | 1.09 | 0.79 |
95% CI | 0.79, 1.08 | 0.84, 1.55 | 0.47, 1.12 | 0.68, 1.74 | 0.66, 1.80 | 0.39, 1.62 |
≤45 years | ||||||
None | ||||||
No. of deaths | 3,374 | 694 | 579 | 303 | 247 | 173 |
HRa | ref | ref | ref | ref | ref | ref |
TAH | ||||||
# of deaths | 595 | 130 | 103 | 49 | 39 | 37 |
HR° | 1.00 | 1.04 | 0.99 | 0.89 | 0.83 | 1.23 |
95% CI | 0.91, 1.09 | 0.85, 1.26 | 0.80, 1.23 | 0.65, 1.22 | 0.58, 1.18 | 0.85, 1.79 |
BSO | ||||||
No. of deaths | 355 | 90 | 52 | 32 | 36 | 26 |
HRa | 0.95 | 1.16 | 0.85 | 0.90 | 1.17 | 1.36 |
95% CI | 0.84, 1.06 | 0.92, 1.47 | 0.63, 1.14 | 0.61, 1.32 | 0.81, 1.70 | 0.88, 2.11 |
<50 years | ||||||
None | ||||||
No. of deaths | 2,957 | 612 | 500 | 268 | 199 | 150 |
HRa | ref | ref | ref | ref | ref | ref |
TAH | ||||||
No. of deaths | 742 | 149 | 123 | 62 | 57 | 46 |
HRa | 0.96 | 0.92 | 0.96 | 0.84 | 1.06 | 1.18 |
95% CI | 0.88, 1.04 | 0.76, 1.11 | 0.78, 1.19 | 0.62, 1.13 | 0.77, 1.45 | 0.83, 1.68 |
BSO | ||||||
No. of deaths | 575 | 144 | 98 | 51 | 64 | 38 |
HRa | 0.89 | 1.08 | 0.97 | 0.81 | 1.40 | 1.17 |
95% CI | 0.81, 0.98 | 0.88, 1.32 | 0.76, 1.22 | 0.58, 1.12 | 1.02, 1.93 | 0.79, 1.73 |
≤55 years | ||||||
None | ||||||
No. of deaths | 2,630 | 557 | 430 | 238 | 175 | 136 |
HRa | ref | ref | ref | ref | ref | ref |
TAH | ||||||
No. of deaths | 783 | 155 | 126 | 65 | 61 | 48 |
HRa | 0.96 | 0.88 | 1.01 | 0.81 | 1.08 | 1.13 |
95% CI | 0.88, 1.04 | 0.73, 1.07 | 0.81, 1.25 | 0.60, 1.09 | 0.79, 1.49 | 0.79, 1.62 |
BSO | ||||||
No. of deaths | 723 | 169 | 127 | 64 | 72 | 47 |
HRa | 0.88 | 0.97 | 1.05 | 0.78 | 1.26 | 1.10 |
95% CI | 0.80, 0.97 | 0.80, 1.18 | 0.84, 1.31 | 0.57, 1.06 | 0.92, 1.72 | 0.76, 1.60 |
BSO, bilateral salpingo-oophorectomy; CI, confidence interval; CRC, colorectal cancer; HR, hazard ratio; NHL, non-Hodgkins lymphoma; TAH, total abdominal hysterectomy.
Landmark analyses, using Cox proportional hazards models, adjusted for body mass index, alcohol use, smoking, menopausal hormone therapy use, and birth cohort.